SCHEMBL13298461

SCHEMBL13298461

c1ccc([SiH2]c2ccc3c(-c4ccccc4)c4ccccc4c(-c4ccccc4)c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.37
▸ ESR1 P03372 6/20 0.37
▸ ESR2 Q92731 6/20 0.37
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ ERAP1 Q9NZ08 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ THRA P10827 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298473 0.90 NOTUM (0.42) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL13298462 0.90 NOTUM (0.42) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL13298474 0.88 IMPDH2 (0.41) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL13298459 0.87 ESR1 (0.40) ESR1ESR2KDM4EALDH1A1ALOX5
SCHEMBL13298463 0.87 ESR1 (0.40) ESR1ESR2KDM4EALDH1A1ALOX5
SCHEMBL13298484 0.86 ALOX5 (0.40) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL13298470 0.86 ALOX5 (0.40) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL13298490 0.86 ESR1 (0.39) ESR1ESR2KDM4EALDH1A1MEN1
SCHEMBL13298460 0.86 THRA (0.36) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL13298483 0.86 THRA (0.36) ESR1ESR2KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 ACHE 535/4885ESR1 226/4885ESR2 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback